SGRY logo

Surgery Partners (SGRY) Cash From Financing

Annual CFF

$262.00 M
+$417.20 M+268.81%

December 31, 2024

Summary

Performance

1-Year Change

+268.81%

3-Year Change

-17.17%

5-Year Change

+292.79%

15-Year Change

-

SGRY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.25%
SGRY annual cash flow from financing activities is higher than 93.25% of companies in Healthcare sector

High & Low

All-time High

$316.30 M
SGRY annual cash flow from financing activities is currently -17.17% below its historical high of $316.30 million

3-Year Low

-$155.20 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
SGRY previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
SGRY next annual earnings announcement has not yet been scheduled

OtherSGRYcash flowmetrics:

Annual CFI

-$488.50 M
SGRY annual cash flow from investing activities is -$488.50 million

Annual CFO

$300.10 M
SGRY annual cash flow from operations is $300.10 million

Annual FCF

$209.70 M
SGRY annual free cash flow is $209.70 million

Annual CAPEX

$90.40 M
SGRY annual capital expenditures is $90.40 million

Quarterly CFF

$48.00 M
+$55.30 M+757.53%

December 31, 2024

Summary

Performance

3-Month Change

+757.53%

1-Year Change

+757.53%

3-Year Change

-79.11%

5-Year Change

-79.11%

SGRY Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.22%
SGRY quarterly cash flow from financing activities is higher than 92.22% of companies in Healthcare sector

High & Low

All-time High

$229.80 M
SGRY quarterly cash flow from financing activities is currently -79.11% below its historical high of $229.80 million

3-Year Low

-$59.30 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SGRY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
SGRY next earnings announcement is scheduled for May 7, 2025

OtherSGRYcash flowmetrics:

Quarterly CFI

-$111.70 M
SGRY quarterly cash flow from investing activities is -$111.70 million

Quarterly CFO

$111.40 M
SGRY quarterly cash flow from operations is $111.40 million

Quarterly FCF

$89.10 M
SGRY quarterly free cash flow is $89.10 million

Quarterly CAPEX

$22.30 M
SGRY quarterly capital expenditures is $22.30 million

TTM CFF

$262.00 M
+$92.60 M+54.66%

December 31, 2024

Summary

Performance

3-Month Change

+54.66%

1-Year Change

+54.66%

3-Year Change

-17.17%

5-Year Change

-17.17%

SGRY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.4%
SGRY TTM cash flow from financing activities is higher than 92.4% of companies in Healthcare sector

High & Low

All-time High

$316.30 M
SGRY TTM cash flow from financing activities is currently -17.17% below its historical high of $316.30 million

3-Year Low

-$155.20 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SGRY previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
SGRY next earnings announcement is scheduled for May 7, 2025

OtherSGRYcash flowmetrics:

TTM CFI

-$488.50 M
SGRY TTM cash flow from investing activities is -$488.50 million

TTM CFO

$300.10 M
SGRY TTM cash flow from operations is $300.10 million

TTM FCF

$209.70 M
SGRY TTM free cash flow is $209.70 million

TTM CAPEX

$90.40 M
SGRY TTM capital expenditures is $90.40 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

SGRY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+268.8%+757.5%+54.7%
3 y3 years-17.2%-79.1%-17.2%
5 y5 years+292.8%-79.1%-17.2%

SGRY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.2%+268.8%-79.1%+180.9%-17.2%+268.8%
5 y5-year-17.2%+268.8%-79.1%+180.9%-17.2%+268.8%
alltimeall time-17.2%+268.8%-79.1%+180.9%-17.2%+268.8%

Surgery Partners Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$262.00 M(-268.8%)
$48.00 M(-757.5%)
$262.00 M(+54.7%)
Sep 2024
-
-$7.30 M(-103.9%)
$169.40 M(+8.4%)
Jun 2024
-
$189.60 M(+498.1%)
$156.30 M(-289.9%)
Mar 2024
-
$31.70 M(-171.1%)
-$82.30 M(-47.0%)
Dec 2023
-$155.20 M(-468.6%)
-$44.60 M(+118.6%)
-$155.20 M(-288.1%)
Sep 2023
-
-$20.40 M(-58.4%)
$82.50 M(+50.3%)
Jun 2023
-
-$49.00 M(+18.9%)
$54.90 M(+23.1%)
Mar 2023
-
-$41.20 M(-121.3%)
$44.60 M(+5.9%)
Dec 2022
$42.10 M(-86.7%)
$193.10 M(-502.3%)
$42.10 M(-46.6%)
Sep 2022
-
-$48.00 M(-19.1%)
$78.80 M(+0.4%)
Jun 2022
-
-$59.30 M(+35.7%)
$78.50 M(-7.4%)
Mar 2022
-
-$43.70 M(-119.0%)
$84.80 M(-73.2%)
Dec 2021
$316.30 M(+374.2%)
$229.80 M(-575.8%)
$316.30 M(+677.1%)
Sep 2021
-
-$48.30 M(-8.9%)
$40.70 M(-74.0%)
Jun 2021
-
-$53.00 M(-128.2%)
$156.50 M(-10.1%)
Mar 2021
-
$187.80 M(-510.0%)
$174.10 M(+161.0%)
Dec 2020
$66.70 M(-149.1%)
-$45.80 M(-167.9%)
$66.70 M(-27.4%)
Sep 2020
-
$67.50 M(-290.7%)
$91.90 M(-566.5%)
Jun 2020
-
-$35.40 M(-144.0%)
-$19.70 M(+69.8%)
Mar 2020
-
$80.40 M(-490.3%)
-$11.60 M(-91.5%)
DateAnnualQuarterlyTTM
Dec 2019
-$135.90 M(+2057.1%)
-$20.60 M(-53.3%)
-$135.90 M(-2128.4%)
Sep 2019
-
-$44.10 M(+61.5%)
$6.70 M(-58.4%)
Jun 2019
-
-$27.30 M(-37.8%)
$16.10 M(+192.7%)
Mar 2019
-
-$43.90 M(-136.0%)
$5.50 M(-187.3%)
Dec 2018
-$6.30 M(-108.8%)
$122.00 M(-451.6%)
-$6.30 M(-95.1%)
Sep 2018
-
-$34.70 M(-8.4%)
-$128.30 M(+37.1%)
Jun 2018
-
-$37.90 M(-32.0%)
-$93.60 M(+74.4%)
Mar 2018
-
-$55.70 M(-2834.4%)
-$53.66 M(+147.7%)
Jun 2017
-
$2.04 M(-104.9%)
-$21.66 M(-47.7%)
Mar 2017
-
-$41.98 M(-436.7%)
-$41.42 M(-158.1%)
Dec 2016
$71.28 M(+113.6%)
$12.47 M(+114.5%)
$71.28 M(-45.6%)
Sep 2016
-
$5.81 M(-132.8%)
$131.06 M(-0.4%)
Jun 2016
-
-$17.73 M(-125.1%)
$131.63 M(+3.7%)
Mar 2016
-
$70.72 M(-2.1%)
$126.89 M(+280.2%)
Dec 2015
$33.37 M(-89.3%)
$72.25 M(+1033.0%)
$33.37 M(-185.8%)
Sep 2015
-
$6.38 M(-128.4%)
-$38.88 M(-14.1%)
Jun 2015
-
-$22.46 M(-1.5%)
-$45.26 M(+98.5%)
Mar 2015
-
-$22.79 M
-$22.79 M
Dec 2014
$310.96 M(-925.7%)
-
-
Dec 2013
-$37.66 M(-12.5%)
-
-
Dec 2012
-$43.06 M
-
-

FAQ

  • What is Surgery Partners annual cash flow from financing activities?
  • What is the all time high annual CFF for Surgery Partners?
  • What is Surgery Partners annual CFF year-on-year change?
  • What is Surgery Partners quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Surgery Partners?
  • What is Surgery Partners quarterly CFF year-on-year change?
  • What is Surgery Partners TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Surgery Partners?
  • What is Surgery Partners TTM CFF year-on-year change?

What is Surgery Partners annual cash flow from financing activities?

The current annual CFF of SGRY is $262.00 M

What is the all time high annual CFF for Surgery Partners?

Surgery Partners all-time high annual cash flow from financing activities is $316.30 M

What is Surgery Partners annual CFF year-on-year change?

Over the past year, SGRY annual cash flow from financing activities has changed by +$417.20 M (+268.81%)

What is Surgery Partners quarterly cash flow from financing activities?

The current quarterly CFF of SGRY is $48.00 M

What is the all time high quarterly CFF for Surgery Partners?

Surgery Partners all-time high quarterly cash flow from financing activities is $229.80 M

What is Surgery Partners quarterly CFF year-on-year change?

Over the past year, SGRY quarterly cash flow from financing activities has changed by +$55.30 M (+757.53%)

What is Surgery Partners TTM cash flow from financing activities?

The current TTM CFF of SGRY is $262.00 M

What is the all time high TTM CFF for Surgery Partners?

Surgery Partners all-time high TTM cash flow from financing activities is $316.30 M

What is Surgery Partners TTM CFF year-on-year change?

Over the past year, SGRY TTM cash flow from financing activities has changed by +$92.60 M (+54.66%)